Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 104

1.

Radioembolization with 90Y Resin Microspheres of Neuroendocrine Liver Metastases: International Multicenter Study on Efficacy and Toxicity.

Braat AJAT, Kappadath SC, Ahmadzadehfar H, Stothers CL, Frilling A, Deroose CM, Flamen P, Brown DB, Sze DY, Mahvash A, Lam MGEH.

Cardiovasc Intervent Radiol. 2019 Jan 2. doi: 10.1007/s00270-018-2148-0. [Epub ahead of print]

PMID:
30603975
2.

Noninvasive Monitoring of Suicide Gene Therapy by Using Multimodal Molecular Imaging.

Holvoet B, Leten C, Deroose CM, Himmelreich U.

Methods Mol Biol. 2019;1895:123-134. doi: 10.1007/978-1-4939-8922-5_10.

PMID:
30539534
3.

An uncommon histopathological diagnosis.

Bode H, Sciot R, Werbrouck E, Geusens E, Deroose CM, Nackaerts K.

Breathe (Sheff). 2018 Dec;14(4):311-316. doi: 10.1183/20734735.027418.

4.

Somatostatin receptor PET ligands - the next generation for clinical practice.

Pauwels E, Cleeren F, Bormans G, Deroose CM.

Am J Nucl Med Mol Imaging. 2018 Oct 20;8(5):311-331. eCollection 2018. Review.

5.

Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group.

Lecouvet FE, Oprea-Lager DE, Liu Y, Ost P, Bidaut L, Collette L, Deroose CM, Goffin K, Herrmann K, Hoekstra OS, Kramer G, Lievens Y, Lopci E, Pasquier D, Petersen LJ, Talbot JN, Zacho H, Tombal B, deSouza NM.

Lancet Oncol. 2018 Oct;19(10):e534-e545. doi: 10.1016/S1470-2045(18)30571-0. Epub 2018 Oct 1. Review.

PMID:
30303127
6.

PET imaging in adaptive radiotherapy of gastrointestinal tumors.

Bulens P, Thomas M, Deroose CM, Haustermans K.

Q J Nucl Med Mol Imaging. 2018 Dec;62(4):385-403. doi: 10.23736/S1824-4785.18.03081-9. Epub 2018 Jun 4. Review.

7.

18F-FDG PET/CT and MRI of a Mediastinal Malignant Granular Cell Tumor With Associated Recurrent Pericarditis.

D'hulst L, Deroose C, Strybol D, Coolen J, Gheysens O.

Clin Nucl Med. 2018 Aug;43(8):589-590. doi: 10.1097/RLU.0000000000002137.

PMID:
29847320
8.

The human somatostatin receptor type 2 as an imaging and suicide reporter gene for pluripotent stem cell-derived therapy of myocardial infarction.

Neyrinck K, Breuls N, Holvoet B, Oosterlinck W, Wolfs E, Vanbilloen H, Gheysens O, Duelen R, Gsell W, Lambrichts I, Himmelreich U, Verfaillie CM, Sampaolesi M, Deroose CM.

Theranostics. 2018 Apr 14;8(10):2799-2813. doi: 10.7150/thno.22980. eCollection 2018.

9.

Tri-modal In vivo Imaging of Pancreatic Islets Transplanted Subcutaneously in Mice.

Liang S, Louchami K, Holvoet B, Verbeke R, Deroose CM, Manshian B, Soenen SJ, Lentacker I, Himmelreich U.

Mol Imaging Biol. 2018 Dec;20(6):940-951. doi: 10.1007/s11307-018-1192-0.

PMID:
29671177
10.

An unusual presentation of a more common disease entity.

Van de Kerkhove C, De Wever W, Verbeken EK, Deroose C, Nackaerts K.

Breathe (Sheff). 2018 Mar;14(1):49-53. doi: 10.1183/20734735.013417.

11.

Mixed response on regorafenib treatment for GIST (gastro-intestinal stromal tumor) according to 18F-FDG-PET/CT.

Van Weehaeghe D, Gheysens O, Vandecaveye V, Schöffski P, Van Laere K, Deroose CM.

BMC Cancer. 2018 Mar 5;18(1):253. doi: 10.1186/s12885-018-4154-7.

12.

Joint Reconstruction of Activity and Attenuation in Time-of-Flight PET: A Quantitative Analysis.

Rezaei A, Deroose CM, Vahle T, Boada F, Nuyts J.

J Nucl Med. 2018 Oct;59(10):1630-1635. doi: 10.2967/jnumed.117.204156. Epub 2018 Mar 1.

PMID:
29496982
13.

Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography-computed tomography?

Decaluwé H, Moons J, Fieuws S, De Wever W, Deroose C, Stanzi A, Depypere L, Nackaerts K, Coolen J, Lambrecht M, Verbeken E, De Ruysscher D, Vansteenkiste J, Van Raemdonck D, De Leyn P, Dooms C; Leuven Lung Cancer Group.

Eur J Cardiothorac Surg. 2018 Jul 1;54(1):134-140. doi: 10.1093/ejcts/ezy018.

PMID:
29447330
14.

MicroRNAs promote skeletal muscle differentiation of mesodermal iPSC-derived progenitors.

Giacomazzi G, Holvoet B, Trenson S, Caluwé E, Kravic B, Grosemans H, Cortés-Calabuig Á, Deroose CM, Huylebroeck D, Hashemolhosseini S, Janssens S, McNally E, Quattrocelli M, Sampaolesi M.

Nat Commun. 2017 Nov 1;8(1):1249. doi: 10.1038/s41467-017-01359-w.

15.

Safety and Efficacy of Transarterial Radioembolisation in Patients with Intermediate or Advanced Stage Hepatocellular Carcinoma Refractory to Chemoembolisation.

Klompenhouwer EG, Dresen RC, Verslype C, Laenen A, De Hertogh G, Deroose CM, Bonne L, Vandevaveye V, Maleux G.

Cardiovasc Intervent Radiol. 2017 Dec;40(12):1882-1890. doi: 10.1007/s00270-017-1739-5. Epub 2017 Jul 6.

PMID:
28685382
16.

Quantitative imaging outperforms molecular markers when predicting response to chemoradiotherapy for rectal cancer.

Joye I, Debucquoy A, Deroose CM, Vandecaveye V, Cutsem EV, Wolthuis A, D'Hoore A, Sagaert X, Zhou M, Gevaert O, Haustermans K.

Radiother Oncol. 2017 Jul;124(1):104-109. doi: 10.1016/j.radonc.2017.06.013. Epub 2017 Jun 21.

17.

Molecular Imaging of Human Embryonic Stem Cells Stably Expressing Human PET Reporter Genes After Zinc Finger Nuclease-Mediated Genome Editing.

Wolfs E, Holvoet B, Ordovas L, Breuls N, Helsen N, Schönberger M, Raitano S, Struys T, Vanbilloen B, Casteels C, Sampaolesi M, Van Laere K, Lambrichts I, Verfaillie CM, Deroose CM.

J Nucl Med. 2017 Oct;58(10):1659-1665. doi: 10.2967/jnumed.117.189779. Epub 2017 Jun 8.

18.

Multipotent adult progenitor cells improve the hematopoietic function in myelodysplasia.

Roobrouck VD, Wolfs E, Delforge M, Broekaert D, Chakraborty S, Sels K, Vanwelden T, Holvoet B, Lhoest L, Khurana S, Pandey S, Hoornaert C, Ponsaerts P, Struys T, Boeckx N, Vandenberghe P, Deroose CM, Verfaillie CM.

Cytotherapy. 2017 Jun;19(6):744-755. doi: 10.1016/j.jcyt.2017.03.009.

19.

Fibrous dysplasia mimicking bone metastasis on 68GA-PSMA PET/MRI.

De Coster L, Sciot R, Everaerts W, Gheysens O, Verscuren R, Deroose CM, Pans S, Van Laere K, Goffin KE.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1607-1608. doi: 10.1007/s00259-017-3712-6. Epub 2017 May 9. No abstract available.

PMID:
28488027
20.

Using PET for therapy monitoring in oncological clinical trials: challenges ahead.

Deroose CM, Stroobants S, Liu Y, Shankar LK, Bourguet P.

Eur J Nucl Med Mol Imaging. 2017 Aug;44(Suppl 1):32-40. doi: 10.1007/s00259-017-3689-1. Epub 2017 Apr 27. Review.

PMID:
28451825

Supplemental Content

Loading ...
Support Center